Behavioral Finance

May 1, 2026

Title 'Action Bias' with a subtitle; four-color grid showing outcomes: Lucky and Confused on gray left, Disciplined Investor and Bias-Trapped on green/orange right.

Action Bias: Bar-Eli et al.’s 2007 Goalkeeper Study and Why Indian Investors’ Compulsion to ‘Do Something’ Destroys Long-Term Returns

Action bias — the compulsion to act when inaction is statistically superior — is the most expensive behavioural mistake in Indian retail investing. Bar-Eli et al. (2007), the SEBI F&O loss data, and Titan Biotech FY25's audited capital-allocation cadence frame the behavioural template every long-term investor needs.

May 1, 2026

Infographic bar chart titled EBITDA Margin; FY20–FY25 margins rise from 14% to 22%, final bar green.

EBITDA Margin: The Profitability Yardstick Every Indian Value Investor Must Master

EBITDA Margin is the cleanest operating-profitability lens for Indian value investors. Educational walkthrough using Titan Biotech FY25 audited numbers — ~18-22% margin, ~103% CFO/OP conversion, near debt-free — to illustrate disciplined specialty-biotech economics. Not a buy/sell recommendation.

May 1, 2026

Dark blue website hero with headline 'Stocks as Equity Bonds' and green subtitle; a 2x2 color-block grid: Trader (gray), Compounder (green), Drift (light gray), Speculator (orange); subtle footer text.

Stocks as Equity Bonds: Warren Buffett’s 1977 Equity-Bond Framework — Why Indian Long-Term Investors Should Treat Every Share Certificate as a Variable-Coupon Bond

Warren Buffett's 1977 Fortune essay reframed every share certificate as a variable-coupon bond. Today's deep-dive explains the equity-bond framework, the three levers (starting yield, reinvestment ROE, retention discipline), and how Titan Biotech FY25 audited numbers illustrate the principle.

April 30, 2026

Mbcover Pre Mortem Analysis Gary Klein Titan Biotech Fy25 960x750 - Manish Goel Portfolio Management Service

Pre-Mortem Analysis: Gary Klein’s 2007 HBR Discipline for Imagining Failure Before You Invest

Gary Klein's 2007 HBR pre-mortem discipline — imagining failure before you click 'Buy' — is the highest-return habit available to Indian retail investors. Plus a 12-question small-cap pre-mortem checklist applied to Titan Biotech FY25 audited numbers as an educational process case study.